Home › Castration-Resistant Prostatic Cancer

Castration-Resistant Prostatic Cancer clinical trials recruiting in the U.S.

17 studies for Castration-Resistant Prostatic Cancer are recruiting participants at sites across the United States.

Cities with the most studies

• Los Angeles, CA7 studies
• Houston, TX6 studies
• New York City, NY6 studies
• Seattle, WA6 studies
• Boston, MA5 studies
• Queens, NY4 studies
• Pittsburgh, PA4 studies
• Philadelphia, PA4 studies
• San Francisco, CA4 studies
• Nashville, TN3 studies
• Cincinnati, OH3 studies
• Minneapolis, MN3 studies
• Dallas, TX3 studies
• Baltimore, MD3 studies
• St. Louis, MO3 studies
• Clifton, NJ3 studies
• Washington, DC3 studies
• Arlington, VA3 studies
• Metairie, LA3 studies
• Myrtle Beach, SC3 studies
• Mountain View, CA3 studies
• Grand Rapids, MI3 studies

By state

• California10 studies
• Connecticut3 studies
• Florida4 studies
• Illinois4 studies
• Louisiana3 studies
• Maryland3 studies
• Massachusetts5 studies
• Michigan7 studies
• Minnesota4 studies
• Missouri3 studies
• New Jersey5 studies
• New York7 studies
• North Carolina4 studies
• Ohio3 studies
• Oregon3 studies
• Pennsylvania5 studies
• South Carolina4 studies
• Tennessee5 studies
• Texas7 studies
• Virginia4 studies
• Washington6 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.